Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Scopus Biopharma Inc

SCPS
Current price
0.0004 USD 0 USD (0.00%)
Last closed 0.0004 USD
ISIN US8091711015
Sector Healthcare
Industry Biotechnology
Exchange OTCMKTS
Capitalization 16 834 USD
Yield for 12 month -99.11 %
1Y
3Y
5Y
10Y
15Y
SCPS
21.11.2021 - 28.11.2021

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs. It offers Duet Platform, which consists of signal transducer and activator of transcription 3 (STAT3), a master immune checkpoint inhibitor and toll-like receptor 9 (TLR9), as well as includes CpG-STAT3ASO (DUET-02), CpG-STAT3siRNA (DUET-01), and CpG-STAT3decoy (DUET-03); and that develops a suite of bifunctional oligonucleotides that activate antigen-presenting cells (APCs) in the tumor microenvironment that alleviates tumor immunosuppression to jump-start T cell-mediated immune responses. The company is also developing DUET-01, as a monotherapy targeting B-cell non-Hodgkin lymphoma; DUET-02 that provides systemic delivery for treatment of solid tumors comprising prostate or kidney cancers; and DUET-03, which targets the actual STAT3 transcription factor protein. Scopus BioPharma Inc. has licensing agreements with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York. Address: 420 Lexington Avenue, New York, NY, United States, 10170

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures SCPS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -9 341 912 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -538.06 %
PEG Ratio
Return On Equity TTM -1559.6 %
Wall Street Target Price 12 USD
Revenue TTM
Book Value -0.24 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.31 USD
Diluted Eps TTM -0.31 USD
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics SCPS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History SCPS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation SCPS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.1208
Price Book MRQ 2.4153

Financials SCPS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SCPS

For 52 weeks

0.0001 USD 0.064 USD
50 Day MA 0.0004 USD
Shares Short Prior Month 38 430
200 Day MA 0.0013 USD
Short Ratio 0.22
Shares Short 23 773
Short Percent 0.25 %